New clinical trial for GD3

Uncategorized

Patients 12 years and older are needed for a clinical research study testing an orally administered treatment in Gaucher disease type 3. This study will evaluate whether an investigational treatment, a substrate reduction therapy, is effective in treating patients 12 years and older with Gaucher disease type 3 while also further evaluating the study drug’s […]

Read more

  • Categories

  • Select Date Range

× How can I help you?